Inspection Record

Norrizon Sales & Marketing Group Inc. — Health Canada Inspection Findings

Health CanadaInspected 2023-09-06 3 findingsEquipment and facilityLabeling and packagingOther quality system

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.

2Labeling and packaging

The importer did not ensure that the foreign sites use to fabricate, package/label, or test drug products met the requirements described in Guidance on Evidence to Demonstrate Drug GMP Compliance of Foreign Sites (GUI-0080).

3Other quality system

The handling of standard operating procedures for good manufacturing practices was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2023-09-06. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

2022-02-02 · Health Canada · 4 findings
Norrizon Sales & Marketing Group Inc. company profile — full history Health Canada documents, 2023 Go to Findings search